Search Results 351-360 of 18161 for monoclonal antibody

  1. Oncology (Medical) - Clinical trials

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  2. Rituximab-abbs (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab-abbs is a monoclonal antibody. Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to ...

  3. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  4. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Staff. December 5, 2020. Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody ...

  5. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  6. Radiation Therapy, Paclitaxel, And Carboplatin With Or Without Trastuzumab In Treating Patients With Esophageal Cancer - Mayo Clinic

    Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. ... monoclonal antibody; Previous history of congestive heart failure ...

  7. Rituximab-arrx (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab-arrx is a monoclonal antibody. Rituximab-arrx injection is also used together with other medicines (eg, fludarabine and cyclophosphamide) to treat ...

  8. Telisotuzumab vedotin-tllv (intravenous route) - Side effects & uses - Mayo Clinic

    Telisotuzumab vedotin-tllv injection is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is ...

  9. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  10. A Study Of DFRF4539A In Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    Prior use of monoclonal antibody within 4 weeks before Cycle 1, Day 1 · Treatment with radiotherapy, thalidomide, lenalidomide, bortezomib, any chemotherapeutic ...